2002
DOI: 10.1067/mob.2002.121103
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
73
0
9

Year Published

2003
2003
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 147 publications
(86 citation statements)
references
References 16 publications
4
73
0
9
Order By: Relevance
“…CCVR has excellent cycle control. (19,20) Cycle control during CCVR use was assessed by vaginal blood loss classified as either withdrawal bleeding (bleeding per vaginum during ring-free week) or irregular bleeding (unpredictable bleeding p/v during CCVR use period). Incidence of withdrawal bleeding occurs in 100% of cycle observed with mean duration of 4.2 days of which early withdrawal bleeding was 1.2% and late withdrawal bleeding was 13.7%.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…CCVR has excellent cycle control. (19,20) Cycle control during CCVR use was assessed by vaginal blood loss classified as either withdrawal bleeding (bleeding per vaginum during ring-free week) or irregular bleeding (unpredictable bleeding p/v during CCVR use period). Incidence of withdrawal bleeding occurs in 100% of cycle observed with mean duration of 4.2 days of which early withdrawal bleeding was 1.2% and late withdrawal bleeding was 13.7%.…”
Section: Resultsmentioning
confidence: 99%
“…The incidence of intended bleeding pattern was 95% which was comparable to studies conducted by Dieden et al (2002), (19) and Bjarnadottir et al (2002). (20) In this study, a 7% increase or decrease in body weight was taken to be clinically significant. Our study showed an increase of 0.2% and decrease of 0.18% which was clinically non-significant.…”
Section: Resultsmentioning
confidence: 99%
“…However, a retrospective analysis of 2893 women (613 of whom were overweight or obese) using two different low-dose oral contraceptive formulations found no difference in breakthrough bleeding or spotting. 30 It can only be presumed that cycle control in obese women using non-oral preparations is equally efficacious.…”
Section: Obesity and Contraceptive Efficacy Combined Hormonal Regimensmentioning
confidence: 99%
“…24 In two studies, the comparator was an oral contraceptive with 30 µg of EE and 150 µg of LNG. 25,26 In the other study, the ring was compared with two different pills, one with 20 µg of EE and 100 µg of LNG, and the other with 15 µg of EE and 60 µg of gestodene. 27 The percentage of women with intermenstrual bleeding in the four studies ranged from 1.1%-9.5%, in the ring groups, and from 3.5%-35.8% in the pill groups.…”
Section: Bleeding Patternmentioning
confidence: 99%